Header cover image
  • Investing Ideas
  • Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts

Results

1

0 new

Companies which are more than 50% undervalued based on analyst price target.

1 companies

Lytix Biopharma

Market Cap: NOK 598.3m

A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.

LYTIX

NOK 7.78

7D

-8.5%

1Y

-16.2%